Dcgi News

DCGI approves anti-Covid drug developed by DRDO for emergency use

DCGI approves anti-Covid drug developed by DRDO for emergency use

New Delhi: A drug to treat coronavirus patients, developed by the DRDO (Defence Research and Development Organisation), has been approved for emergency use by the country’s top drugs controller as India battles the second wave of the pandemic that is killing thousands every day.The drug comes in powder form in

DCGI approves Zydus Cadila’s anti-COVID-19 drug Virafin for emergency use

DCGI approves Zydus Cadila’s anti-COVID-19 drug Virafin for emergency use

The Drugs Controller General of India (DGCI) on Friday granted restricted emergency use approval to Zydus Cadila’s anti-COVID-19 drug ‘Virafin.’ Virafin, or Pegylated Interferon alpha-2b (PegIFN), will be used for treating moderate COVID-19 infection in adults. A single-dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient

X